Orexin B, human TFA
Orexin B, human TFA 用途与合成方法
Ki: 420 nM (OX1), 36 nM (OX2).
Orexin B is derived by proteolytic amino acid precursor, prepro-orexin, which is encoded by a gene localized to chromosome 17q21 in humans. In radioligand binding studies, Orexin B has a higher affinity for the OX2 receptor.
Human Orexin B has two amino acid substitutions when compared with the rodent sequence. OX2 receptor is indeed a high-affinity receptor for human orexin B, with an IC
50
of 36 nM in the binding assay and an EC
50
of 60 nM in the [Ca
2+
]i transient assay. Human Orexin B has significantly lower affinity for the human OX1: the calculated IC
50
in the competitive binding assay and the EC
50
in the [Ca
2+
]i transient assay are 420 nM and 2500 nM for human orexin-B, respectively.
Human Orexin B significantly augments food intake; at the 2 hr time point, 5- and 12-fold stimulation of food consumption is observed by 3 nM and 30 nM orexin-B, respectively.
| Animal Model: | Male Wistar rats (180-200 g). |
| Dosage: | 3 nM and 30 nM. |
| Administration: | Administered in a 5 mL bolus through a catheter placed in the left lateral ventricle in early light phase. |
| Result: | Significantly augmented food intake. |
